Machine learning in pain research.
Jörn Lötsch, Alfred Ultsch
https://pubmed.ncbi.nlm.nih.gov/29194126/Actively Recruiting
Led by ETH Zurich · Updated on 2025-01-20
150
Participants Needed
4
Research Sites
2 weeks
Total Duration
Researchers are studying chronic nociceptive and neuropathic pain, focusing on both physical and emotional components. The study aims to improve pain monitoring and treatment by using advanced Artificial Intelligence AI and wearable sensors to better understand patients multidimensional pain experiences. This approach addresses challenges in traditional pain management, such as unspecific drug use and high healthcare costs, and seeks to provide more personalized care. Participants will be monitored using a novel telemonitoring system that includes wearable robotic sensors to measure physiological data like skin conductance, blood volume pressure, heart rate, and activity. A digital platform will collect psychological assessments, medication use, pain levels, and sleep quality. An AI engine will analyze all collected data to characterize the nature of each patients pain. The system collects data continuously during normal daily and nightly activities. During the study, participants pain levels, psychosocial and physiological aspects of pain, psychological and clinical factors, and medication intake will be tracked for up to one month. Additional measures include rehabilitation effects, sleep and activity correlations, predictors of pain chronification, quality of life, and medication responsiveness. This observational study involves no intervention, and participants include both pain sufferers and healthy controls who will be monitored and assessed using questionnaires and wearable technology.
CONDITIONS
Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool
A
Andrea Cimolato, PhD
N
Noemi Gozzi
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
ETH Zurich
Lead Sponsor
Balgrist University Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to one month
Participants wear robotic wearable sensors and use a digital platform to collect physiological, psychosocial, and pain-related information during their normal daily activities.
Continuous monitoring during the study period
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jörn Lötsch, Alfred Ultsch
https://pubmed.ncbi.nlm.nih.gov/29194126/Marcella May, Doerte U Junghaenel, Masakatsu Ono...
https://pubmed.ncbi.nlm.nih.gov/29371113/Steven P Cohen, Lene Vase, William M Hooten
https://pubmed.ncbi.nlm.nih.gov/34062143/Irene Tracey, Clifford J Woolf, Nick A Andrews
https://pubmed.ncbi.nlm.nih.gov/30844399/Anna L Kratz, Dawn M Ehde, Charles H Bombardier...
https://pubmed.ncbi.nlm.nih.gov/27919770/Nora D Volkow, A Thomas McLellan
https://pubmed.ncbi.nlm.nih.gov/27028915/Karen D Davis, Nima Aghaeepour, Andrew H Ahn...
https://pubmed.ncbi.nlm.nih.gov/32541893/ETH Zurich
Lead Sponsor
Balgrist University Hospital
Collaborating Sponsor